Table 3.
Antimicrobial resistance of Salmonella spp. strains.
| Antimicrobial | Susceptible | Intermediate | Resistant | Non-Susceptible | |||||
|---|---|---|---|---|---|---|---|---|---|
| No. | % | No. | % | No. | % | No. | % | ||
| Fluoroquinolones | NA | 26 | 89.66 | 1 | 3.45 | 2 | 6.90 | 3 | 10.34 |
| CIP | 27 | 93.10 | 2 | 6.90 | 0 | 0.00 | 2 | 6.90 | |
| ENR | 24 | 82.76 | 5 | 17.24 | 0 | 0.00 | 5 | 17.24 | |
| Penicillins | AMP | 17 | 58.62 | 3 | 10.34 | 9 | 31.03 | 12 | 41.38 |
| AMC | 27 | 93.10 | 2 | 6.90 | 0 | 0.00 | 2 | 6.90 | |
| Cephems (cephalosporins) | CTX | 24 | 82.76 | 5 | 17.24 | 0 | 0.00 | 5 | 17.24 |
| KF | 24 | 82.76 | 4 | 13.79 | 1 | 3.45 | 5 | 17.24 | |
| CAZ | 29 | 100.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | |
| Aminoglycosides | CN | 29 | 100.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| K | 12 | 41.38 | 16 | 55.17 | 1 | 3.45 | 17 | 58.62 | |
| S | 3 | 10.34 | 12 | 41.38 | 14 | 48.28 | 26 | 89.66 | |
| AK | 26 | 89.66 | 2 | 6.90 | 1 | 3.45 | 3 | 10.34 | |
| TOB | 21 | 72.41 | 7 | 24.14 | 1 | 3.45 | 8 | 27.59 | |
| Tetracyclines | TE | 12 | 41.38 | 1 | 3.45 | 15 | 51.72 | 16 | 57.14 |
| TGC | 1 | 3.45 | 21 | 72.41 | 7 | 24.14 | 28 | 96.55 | |
| Folate pathway inhibitors | S3 | 6 | 20.69 | 1 | 3.45 | 22 | 75.86 | 23 | 79.31 |
| W | 28 | 96.55 | 0 | 0.00 | 1 | 3.45 | 1 | 3.45 | |
| SXT | 28 | 96.55 | 0 | 0.00 | 1 | 3.45 | 1 | 3.45 | |
| Others | CT | 29 | 100.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| F | 16 | 55.17 | 6 | 20.69 | 7 | 24.14 | 13 | 44.83 | |
| C | 27 | 93.10 | 1 | 3.45 | 1 | 3.45 | 2 | 6.90 | |
| FFC | 26 | 89.66 | 3 | 10.34 | 0 | 0.00 | 3 | 10.34 | |
Legend: AMC = amoxicillin-clavulanic acid, AMP = ampicillin, AK = amikacin, KF = cephalothin, CTX = cefotaxime, CAZ = ceftazidime, C = chloramphenicol, CIP = ciprofloxacin, CT = colistin, ENR = enrofloxacin, FFC = florphenicol, CN = gentamycin, K = kanamycin, NA = nalidixic acid, F = nitrofurantoin, S = streptomycin, STX = sulfamethoxazolo-trimethoprim, S3 = sulfonamide, TE = tetracycline, TGC = tigecycline, TOB = tobramycin, W trimethoprim.